Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric Cancer
CONCLUSION: In summary, leveraging CSV as a universal CTCs marker represents a significant breakthrough in advancing personalized medicine for patients with advanced GC. This research not only paves the way for tailored therapeutic strategies but also underscores the pivotal role of CSV in enhancing GC management, opening new frontiers for precision medicine.PMID:38685125 | DOI:10.1186/s13046-024-03043-6
Source: Cell Research - Category: Cytology Authors: Heming Li Yang-Zhuangzhuang Zhu Lu Xu Tao Han Jiasi Luan Xin Li Yuting Liu Zhi Wang Qiuge Liu Xiangyu Kong Chunpu Zou Lin Su Yifei Hou Xiao Chen Lujun Chen Ruoyu Wang Zihang Xu Mingfang Zhao Source Type: research
More News: Cancer | Cancer & Oncology | Cytology | Eating Disorders & Weight Management | Epithelial Cancer | Gastric (Stomach) Cancer | Gastroenterology | Genetics | Insulin | Obesity | Radiology | Study | Translocation